Jim Cramer recently highlighted Eli Lilly and Company (LLY) as a standout example of corporate efficiency, praising its ability to build a factory in record time. The factory, located in Concord, ...

We recently published a list of Jim Cramer Reacts to the Surprise Market Surge and Highlights 8 Key Stocks In this article, ...

In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer analyzed the extraordinary market turnaround following ...

Lilly is planning to major in pre-physical therapy at Concord, with the athletic training ... free concessions at Coastal Carolina, and more.

Clearly that was the case for Lady Bobcats senior Avery Lilly, who dreamed of not only donning the Summers County jersey, but also taking her talent to the collegiate level. × This page requires ...

Ranked at the 21st spot in the shooting guard position and fourth in North Carolina (per On3), Eli Ellis received interest from programs including College of Charleston, Winthrop, Mississippi ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets, valued at more than $100 billion. Each of them has advantages, as well as dark spots in the pipeline of ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will prevent heart attacks and strokes. By Gina Kolata As many as one in five ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other billionaire Ken Fisher’s top growth stock picks. “Who am I to tell you anything ...

South Carolina basketball commit Eli Ellis was featured in a new Under ... the 12th-best point guard and the 5th-best player in the state of North Carolina. Ellis has been committed to the South ...

CEOs from large pharma companies AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GSK, Merck KGaA, Pfizer and Sanofi were among more than 40 international business leaders who met with Xi in ...

European Committee Says Lilly Alzheimer's Drug Shouldn't Get Marketing Approval A European regulatory committee rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over ...